These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6287579)
81. Benzodiazepine withdrawal syndrome after a benzodiazepine antagonist. Lopez A; Rebollo J Crit Care Med; 1990 Dec; 18(12):1480-1. PubMed ID: 2245627 [No Abstract] [Full Text] [Related]
82. Pharmacokinetics of nordiazepam in physical dependence and precipitated abstinence in dogs. Wala EP; Martin WR; Sloan JW Pharmacol Biochem Behav; 1993 Apr; 44(4):857-64. PubMed ID: 8469696 [TBL] [Abstract][Full Text] [Related]
83. Diazepam and discriminative motor control: acute, chronic and withdrawal effects. Culberson JW; Tang M; Lau CE; Falk JL Pharmacol Biochem Behav; 1990 Feb; 35(2):419-27. PubMed ID: 2320651 [TBL] [Abstract][Full Text] [Related]
84. Intravenous anaesthesia with a new benzodiazepine Ro 5-4200. Stovner J; Endresen R; Osterud A Acta Anaesthesiol Scand; 1973; 17(3):163-9. PubMed ID: 4754117 [No Abstract] [Full Text] [Related]
85. Effects of caffeine in diazepam withdrawal syndrome in mice. Pesce ME; Acevedo X; Miranda HF Pharmacol Toxicol; 1993; 72(4-5):341-2. PubMed ID: 8372058 [No Abstract] [Full Text] [Related]
86. Failed prevention of benzodiazepine withdrawal symptoms due to spontaneous expulsion of diazepam suppository administrated via stoma: A case report. Yamada Y; Fujiwara M; Torigoe M; Takaki M PCN Rep; 2024 Sep; 3(3):e70001. PubMed ID: 39175531 [No Abstract] [Full Text] [Related]
87. Discriminative stimulus effects of ethanol and 3 alpha-hydroxy-5 alpha-pregnan-20-one in relation to menstrual cycle phase in cynomolgus monkeys (Macaca fascicularis). Grant KA; Azarov A; Shively CA; Purdy RH Psychopharmacology (Berl); 1997 Mar; 130(1):59-68. PubMed ID: 9089848 [TBL] [Abstract][Full Text] [Related]
88. The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance. Gallo AT; Addis S; Martyn V; Ramanathan H; Wilkerson GK; Bennett KS; Hood SD; Stampfer H; Hulse GK Ther Adv Psychopharmacol; 2023; 13():20451253231156400. PubMed ID: 36937113 [TBL] [Abstract][Full Text] [Related]
89. Effects of cannabinoid exposure on short-term memory and medial orbitofrontal cortex function and chemistry in adolescent female rhesus macaques. Kohut SJ; Cao L; Mintzopolous D; Jiang S; Nikas SP; Makriyannis A; Zou CS; Jensen JE; Frederick BB; Bergman J; Kangas BD Front Neurosci; 2022; 16():998351. PubMed ID: 36248648 [TBL] [Abstract][Full Text] [Related]
90. Tolerance and dependence following chronic alprazolam treatment in rhesus monkeys: Role of GABA Duke AN; Tiruveedhula VVNPB; Sharmin D; Knutson DE; Cook JM; Platt DM; Rowlett JK Drug Alcohol Depend; 2021 Nov; 228():108985. PubMed ID: 34500240 [TBL] [Abstract][Full Text] [Related]
91. Tolerance and dependence following chronic alprazolam treatment: quantitative observation studies in female rhesus monkeys. Duke AN; Platt DM; Rowlett JK Psychopharmacology (Berl); 2020 Apr; 237(4):1183-1194. PubMed ID: 31927603 [TBL] [Abstract][Full Text] [Related]
92. Drug Discrimination and the Analysis of Private Events. Kangas BD; Maguire DR Behav Anal (Wash D C); 2016 Nov; 16(4):159-168. PubMed ID: 27928551 [TBL] [Abstract][Full Text] [Related]
93. The discriminative stimulus effects of mecamylamine in nicotine-treated and untreated rhesus monkeys. Cunningham CS; Moerke MJ; McMahon LR Behav Pharmacol; 2014 Aug; 25(4):296-305. PubMed ID: 24978703 [TBL] [Abstract][Full Text] [Related]
94. Prediction and Prevention of Prescription Drug Abuse: Role of Preclinical Assessment of Substance Abuse Liability. Marusich JA; Lefever TW; Novak SP; Blough BE; Wiley JL Methods Rep RTI Press; 2013 Jul; ():1-14. PubMed ID: 24008590 [TBL] [Abstract][Full Text] [Related]
95. Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. Blasio A; Iemolo A; Sabino V; Petrosino S; Steardo L; Rice KC; Orlando P; Iannotti FA; Di Marzo V; Zorrilla EP; Cottone P Neuropsychopharmacology; 2013 Nov; 38(12):2498-507. PubMed ID: 23793355 [TBL] [Abstract][Full Text] [Related]
96. Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation. Fischer BD; Teixeira LP; van Linn ML; Namjoshi OA; Cook JM; Rowlett JK Psychopharmacology (Berl); 2013 May; 227(2):347-54. PubMed ID: 23354533 [TBL] [Abstract][Full Text] [Related]
97. Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes. Ator NA; Atack JR; Hargreaves RJ; Burns HD; Dawson GR J Pharmacol Exp Ther; 2010 Jan; 332(1):4-16. PubMed ID: 19789360 [TBL] [Abstract][Full Text] [Related]
98. Changes in relative potency among positive GABA(A) receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys. McMahon LR; Javors MA; France CP Psychopharmacology (Berl); 2007 May; 192(1):135-45. PubMed ID: 17245585 [TBL] [Abstract][Full Text] [Related]
100. Enhancement of acetylcholine release by flumazenil in the hippocampus of rats chronically treated with diazepam but not with imidazenil or abecarnil. Dazzi L; Motzo C; Maira G; Sanna A; Serra M; Biggio G Psychopharmacology (Berl); 1995 Sep; 121(2):180-5. PubMed ID: 8545523 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]